Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Evidence-based Indications for PDT outside the TAP and VIP Trial

Bunse A.
Klinik für Ophthalmologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel

In the treatment of Age-related Maculadegeneration (AMD) Photodynamic Therapy (PDT) with Verteporfin is established. The two multicenter trials TAP (Treatment of Age-related Maculadegeneration with Photodynamic Therapy) and VIP (Verteporfin in Photodynamic Therapy) show a significant stabilisation of visual function following PDT-treatment compared to a placebo-treated group of patients. These effects are evident for classic and occult choroidal neovascularisations (CNV) of AMD. The therapeutic mechanism of PDT can be used to treat other diseases of the central retina such as Angoid streaks and POHS. In addition choroidal Hemangiomas can be treated by PDT. This contribution discusses indications for PDT-treatment outside the TAP and VIP trials. Recent publications and examples will be demonstrated.


Zurück | Back